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Chronic rhinosinusitis (CRS) is a chronic inflammatory disease that can be 
subdivided into chronic rhinosinusitis sans nasal polyps (CRSsNP), chronic rhinosinusitis 
with nasal polyps (CRSwNP), and aspirin-exacerbated respiratory disease (AERD). Nasal 
polyps are a hallmark feature of CRSwNP and AERD. Although, the pathophysiology of 
polypogenesis is thought to be multifactorial, type 2 (allergic-type) immune responses 
and epithelial remodeling are considered to be central features. In polyp disease, 
epithelial remodeling and dysfunction leads to decreased epithelial diversity, with 
increased basal cells and decreased goblet and ciliated cells. A role for Wnt signaling is 
well established in cancer and fibrotic diseases, and recent studies have indicated that 
Wnt signaling is also upregulated in sinonasal polyposis, a non-cancerous disease. Wisp1, 
a downstream mediator of the Wnt pathway, is significantly increased in polyp disease 
compared to non-polyp disease. Wnt pathway ligands have been reported to induce the 
proliferation and impair differentiation of airway basal cells, but the direct effect of the 
downstream Wnt pathway gene, Wisp1, on respiratory basal epithelial cells is unknown. 
This study aims to investigate the role of Wisp1 on the proliferation, cell migration, and 
differentiation of human respiratory epithelial cells. 
   vi 
In the current study, we found increased expression of WISP1 in nasal polyps 
examined directly ex vivo. Histological analysis of nasal polyps and WISP1 expression in 
primary basal epithelial cell cultures suggested epithelial production of Wisp1 as a 
feature of nasal polyposis. Using submerged and air-liquid interface (ALI) cell cultures, 
the effect of Wisp1 on proliferation, cell migration and differentiation was investigated.  
Increased basal cell accumulation and loss of differentiation are hallmarks of 
sinonasal polyposis. The chronic inflammatory environment present in polyp disease 
includes chronic increased WISP1 expression, which endorses a role for this protein in 
disease. The results of this study suggest that prolonged exposure to Wisp1 may lead to 
an increase in the cellular mass of  respiratory basal epithelial cells, while limiting their 
ability to differentiate, thus allowing for unchecked accumulation. Taken together, our 
results suggest that Wisp1 may contribute to central features of nasal polyposis, thus 
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Rhinosinusitis is an inflammatory disease of the nasal and paranasal sinus mucosa, 
categorized by duration as acute (<4 weeks), subacute (4-12 weeks), and chronic (>12 
weeks)1. With nasal obstruction, excess mucus production, and anosmia, chronic 
rhinosinusitis is one of the most common chronic conditions. Some studies suggest 5-
15% prevalence in the United States and Europe1,2.  In addition to clinical symptoms and 
functional impairment, chronic rhinosinusitis (CRS) greatly impacts ones quality of life 
and productivity, and is associated with comorbities such as asthma and allergic rhinitis3. 
Epidemiologic data suggests that the incidence of CRS is increasing1. To date there are 
limited efficacious, lasting treatments for CRS; thus, there is great emphasis for 
continued investigation into the cellular and molecular mechanisms that contribute to the 
disease.  
The chronic inflammation characteristic of CRS has been associated with a wide 
range of environmental and individual predispositions4. CRS patients present with a 
spectrum of symptoms; thus, the disease has been commonly categorized into two 
groups: CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). 
Nasal polyps are edematous, inflammatory outgrowths that protrude from the ethmoid 
sinus into the nasal airway. Polyps are characterized by a type 2 (allergic-type) immune 
response with pronounced eosinophilia5. In a retrospective chart review conducted by 
Benjamin et al, (2019), it was found that out of 5,525 patients with confirmed CRS, 
approximately 20% met the diagnostic criteria for CRSwNP and 80% for CRSsNP3.  
 
    
2 
CRS and the Type 2 Immune Response 
 
The pathophysiology of CRS remains incompletely understood. Various 
contributing inflammatory pathways have been proposed to be involved in the abnormal 
immune responses seen in CRS. CRSwNP is often observed in conjunction with asthma 
and allergic rhinitis, and is thought to be due to the type 2 inflammation that occurs in the 
three disease states. Type 2 inflammation  is the characterized by a gene expression 
profile involving the expression of cytokines including interleukin-4 (IL-4), IL-5, and IL-
13 produced by T helper 2 (TH2) cells and innate lymphoid cells (ILC2)6. In a type 2 
immune response, epithelial-derived cytokines including IL-25, IL-33, and thymic 
stromal lymphopoietin (TSLP), are released following allergen exposure or other 
inflammatory stimuli. These epithelial-derived cytokines can initiate or enhance the type 
2 immune response, by promoting the production of CD4+ TH2 cells in peripheral 
lymphoid tissue7. The release of type 2 cytokines from TH2 cells collectively stimulate B 
cell proliferation, IgE production, tissue eosinophilia, and goblet cell hyperplasia (Figure 
1). A study by Stevens et al. (2015) supported the strong type 2 response by comparing 
inflammatory mediators found in sinus tissue of CRSwNP and control patients. CRSwNP 
patients had significantly higher IL-5, IL-13, and eotaxin-1, eotaxin-2, eotaxin-3, and 
MCP-4 levels, which supports the type 2 immune response and reinforces the observed 
eosinophilia in CRSwNP patients8.  
 
 












CRSwNP and CRSsNP can be distinguished not only by the presence of nasal 
polyps, but also by the dominant features of the respective immune reactions. CRSwNP 
is frequently characterized by a type 2 immune response, while CRSsNP has been 
attributed to a predominant type 1 response9. In a study by Van Zele et al., (2006) that 
aimed to distinguish CRS subtypes based on inflammatory mediators, it was 
Figure 1. Type 2 immune response. Upon antigen recognition by the epithelium, 
epithelial-derived cytokines initiate and reinforce the type 2 immune response. Among 
other things, IL-25, IL-33, and TSLP promote the activation of CD4+ TH2 cells by 
dendritic cells in peripheral lymphoid tissue. CD4+ TH2 cells secrete type 2 cytokines, 
specifically IL-13, IL-5, and IL-4, which cause goblet cell hyperplasia, eosinophilia, and 
B cell proliferation and IgE production, respectively. ©Charlotte Hansen, drawn with 
BioRender.com  
 
    
4 
demonstrated that CRSsNP tissue samples had significantly greater levels of interferon 
(IFN)-	𝝲, which were largely absent in CRSwNP tissue samples. CRSwNP was 
differentiated by significantly higher levels of IL-5, in addition to heightened eosinophilia 
and serum IgE. The authors concluded that CRSwNP was largely a type 2 polarized 
response and CRSsNP was a type 1 polarized response9. In retrospect, the results of the 
study by Van Zele et al., (2006) had a significant limitation: only 10 CRSwNP and 8 
CRSsNP tissue samples were analyzed. It is known that CRS presents as a spectrum of 
disease and subsequent studies have highlighted the diversity among CRS tissue samples. 
To fully grasp the inflammatory makeup of the disease, there has been an emphasis on 
larger sample sizes to ensure generalizability of results. To avoid the bias of CRSwNP 
and CRSsNP phenotypic classifications, a recent study divided approximately 700 CRS 
patients into inflammatory endotypes classified by cytokines. As expected, the study 
identified groupings with TH2-derived mediators (IL-5, IgE) and those with markers of 
the type 1 response, such as IFN-gamma. While the authors confirmed that patients with 
a predominant type 2 response included those with CRSwNP, type 2 responses were also 
seen in CRSsNP to a significant extent. Further, the type 1 response was proposed to 
contribute less in CRSsNP than previously described10. These findings were further 
validated by Stevens et al., (2015), in which no significant differences were found in the 
gene expression profiles of CRSsNP and CRSwNP patients, with respect to IFN-gamma8. 
Taken together, these studies highlight diverse and mixed type inflammation in CRS.  
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Epithelial Dysfunction and Remodeling in CRS 
As described above, there is evidence of immune involvement in the development 
and progression of CRS. Epithelial dysfunction and remodeling are also hallmarks of 
CRS, and represent another notable disease-contributing mechanism. Efficient 
functioning of the epithelial barrier, the mucocilliary escalator, and innate antimicrobial 
immune responses are critical to the normal function of the respiratory tract. Alterations 
in epithelial homeostasis may make the respiratory epithelium more prone to the 
inflammation characteristic of CRS. Smooth muscle hypertrophy and hyperplasia, 
epithelial cell hyperplasia and dysplasia, and basement membrane thickening are 
structural changes that have been observed in CRSwNP epithelial remodeling11. Similar 
epithelial dysregulation has been described in asthma and other lung diseases12.  
Recent studies have used single-cell RNA sequencing to better understand the 
baseline and disease-associated cell changes in respiratory epithelium. A recent paper by 
Travaglini et al., (2020) used droplet- and plate-based single cell RNA sequencing 
(scRNA-seq) to generate a comprehensive human lung cell atlas using gene expression 
profiles. The most abundant epithelial cells were ciliated cells, club cells, basal cells, 
goblet cells, and alveolar epithelial type 1 and type 2 cells. FOXJ1, CYP2F2, KRT5 and 
p63, MUC5AC, AGER, and SFTPB were the most distinguishable genes of the epithelial 
cells, respectively13. The respiratory epithelium is a pseudostratified epithelium in which 
basal cells that exhibit stem cell-like properties, differentiate into ciliated and secretory 
cells14. Epithelial barrier dysfunction is an ongoing area of research due to significant 
differences seen between CRSwNP tissue and healthy tissue. Nasal polyp tissue shows 
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evidence of functionally abnormal epithelium, particularly epithelial cell hyperplasia15.  
In nasal polyps, ectopic p63 – a basal cell marker – expression has been seen in several 
layers of the epithelium. A study that compared the expression of p63+ cells in CRSwNP 
and control samples demonstrated that there was significantly higher expression of p63 in 
the hyperplastic epithelium of CRSwNP tissue samples compared with inferior turbinate 
tissue obtained during septoplasty to correct septal deviation in otherwise healthy 
subjects.  Additionally, Ki67, a marker for active cell proliferation, was found to be 
localized to p63+ basal cells, while low expression was seen in ciliated and goblet cells. 
These findings suggest epithelial remodeling. Furthermore, expression of Ki67 positively 
correlated with severity of epithelial remodeling and disease in CRSwNP16. Epithelial 
barrier dysfunction also differentiates CRSwNP from CRSsNP. IN CRSwNP, the 
epithelium is characterized by reduced epithelial diversity, particularly increased basal 
cells and decreased ciliated cells and mucus producing cells17 (Figure 2). The factors that 

















Wnt Signaling is Upregulated in CRSwNP 
 
Wnt signaling is thought to play a central role in cancer, wound healing, and 
inflammation18. A study by Boscke et al., (2017) investigated the involvement of Wnt 
signaling in CRSwNP and whether the pathway could be responsible for initiating and 
sustaining the cycle of inflammation and epithelial remodeling seen in CRSwNP. Using 
nasal polyp tissue and healthy inferior turbinate tissue as a control, Boscke et al., (2017) 
performed microarray analysis and quantitative PCR (qPCR) and found that several Wnt 
pathway genes were significantly upregulated in polyp tissue compared to the control. 
Relative expression of WNT2B, WNT3A, WNT4, WNT7A, WNT7B, FZD2, FZD4, 
Figure 2. Epithelial barrier dysfunction distinguishes CRSsNP and CRSwNP. A) 
The CRSsNP epithelium more similarly represents the normal pseudostratified 
respiratory epithelium. Basal-cells with stem cell-like properties differentiate into 
ciliated and goblet cells. B) Epithelial remodeling and barrier dysfunction seen in 
CRSwNP results in reduced epithelial diversity. The CRSwNP epithelium is 
characterized by basal cell hyperplasia, with a reduction in ciliated and goblet cells. 
©Charlotte Hansen, drawn with BioRender.com 
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FZD7, LRP5, LRP6, WIF1, and WISP1 were all significantly different compared to 
control tissue. To test whether Wnt signaling could drive inflammation in polyps, Boscke 
et al., (2017) treated human nasal epithelial cells (HNEpC) with upstream Wnt pathway 
receptor ligands, WNT3A and WNT4A. WNT3A was reported to increase IL-6; 
however, WNT4A had no significant effect on cytokine secretion. Using air-liquid 
interface cell cultures as a model of the in vivo respiratory epithelium, the authors found 
that undifferentiated HNEpC’s treated with WNT3A resulted in reduced basal cell 
differentiation into ciliated cells and caused a flattened, elongated cell morphology. The 
altered cytokine release, state of differentiation, and cell morphology are characteristics 
common to tissue remodeling in CRSwNP18. The authors concluded that Wnt pathway 
activation can sustain the inflammatory milieu and epithelial remodeling characteristic of 
CRSwNP. 
RNA sequencing (RNA-seq) of diseased sinonasal tissue has also revealed an altered 
balance in Wnt signaling17. Ordovas-Montanes et al., (2018) performed bulk and single 
cell RNA-seq on surgical biopsies of subjects with CRSwNP, aspirin-exacerbated 
respiratory disease (AERD), CRSsNP, and concha bullosa (CB) to reveal the 
transcriptomes of human respiratory epithelial, immune, and stromal cells in these 
disease states. Marked differences were reported between the epithelial cell transcripts of 
polyp and non-polyp tissue that validated the global reduction in epithelial diversity and 
basal cell hyperplasia. Importantly, the authors noted increased expression of the 
hallmark Wnt pathway gene17. In healthy epithelium, an intricate balance is required of 
Wnt signaling to maintain the homeostasis of stem and progenitor cells 19. The imbalance 
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in Wnt signaling was further supported by Ordovas-Montanes et al., (2018), in which 
significantly increased baseline expression of β-catenin was reported in polyp tissue 
compared to non-polyp tissue. β-catenin is a downstream effector of Wnt signaling 
activated by inhibition of β-catenin  degradation by Wnt proteins; thus, one can infer 
overall Wnt pathway activation by increased β-catenin expression17,20.   
Previous work has revealed the role of Wnt downstream mediators in the CRSwNP 
pathophysiology. Microarray analysis of CRSwNP samples done by Boscke et al., (2017) 
highlighted WNT-inducible signaling pathway protein 1 (Wisp1) as up-regulated in 
CRSwNP samples compared to control. Secreted by fibroblasts and epithelial cells, 
Wisp1 is a matricellular protein and a member of the CCN protein family21. CCN protein 
family members share a conserved structure consisting of four structural domains: 
insulin-like growth factor binding protein-like domain (IGFBP), von Willebrand factor 
type C repeat domain (VWC), thrombospondin-homology type 1 domain (TSP1), and C-
terminal cysteine-knot-containing domain (CT)22. In particular, Wisp1 has been an 
attractive research target due to its reported role in organ development and disease, 
specifically influencing proliferation, and extracellular matrix deposition23. Wisp1 
expression has been reported in several healthy adult human tissues. Using qualitative 
polymerase chain reaction (qPCR) to amplify cDNA collected from multiple human 
tissue panels, Wisp1 expression was most notably seen in the heart, kidneys, lungs, 
pancreas, placenta, ovaries, small intestine, stomach, and spleen24. In addition to healthy 
adult tissue, Wisp1 is also expressed during embryogenesis, including lung branching 
morphogenesis. In a study that aimed to profile the expression of genes involved in the 
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various phases of lung development, it was reported that Wisp1 expression was high 
during the pseudoglandular stage of lung development, during which the respiratory tree 
is configured. Conversely, Wisp1 expression was low during epithelial differentiation in 
the canalicular phase of lung development23. Although Wisp1 is expressed to some 
degree in several normal adult tissues, aberrant expression has been implicated in several 
disease states, and injury and repair. Idiopathic pulmonary fibrosis (IPF) is characterized 
by excess extracellular matrix deposition, alveolar epithelial type II (ATII) cell 
hyperplasia and injury, and myofibroblast activation25. In human IPF lung tissue samples, 
Wisp1 had the greatest increase in relative mRNA level in IPF tissue compared to control 
tissue. To further validate these findings, quantitative reverse transcription polymerase 
chain reaction (RT-qPCR) of cDNA from primary ATII cells revealed that Wisp1 was 
upregulated in ATII cells obtained from IPF patients compared to a control. Interestingly, 
there was no difference in the Wisp1 expression obtained from IPF derived primary 
fibroblasts21. Furthermore, treatment of ATII cells with 1 µg/mL of Wisp1 resulted in 
ATII cell proliferation, increased extracellular matrix secretion from lung fibroblasts, and 
an increase in the expression of genes upregulated in epithelial-mesenchymal transition 
(EMT), specifically FSP1 and ACTA2. The induction of EMT by Wisp1 was further 
supported by the transformation of ATII cells, as indicated by a loss of epithelial cells 
markers and a gain of mesenchymal cell markers. Taken together, these findings 
highlight the proliferative and profibrotic effects of Wisp1 and its potential to disrupt 
epithelial-mesenchymal crosstalk21. 
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Several studies report the proliferative and fibrotic effect of Wisp1 in cancer, fibrosis, 
and injury and repair. While the importance of Wnt signaling in airway epithelium has 
been suggested by multiple studies, the impact of Wisp1 on the upper airway respiratory 
epithelium across the CRS disease spectrum has not been tested. In the present study, we 
sought to evaluate the role of Wisp1 on the human nasal epithelium. Herein, we used 
submerged human respiratory basal epithelial cell cultures and ALI culture systems to 
examine the impact of Wisp1 on nasal epithelium. The studies described above provide 
the rationale for these studies. The central hypothesis of this study is that Wisp1 
signaling in nasal epithelial cells leads to increased proliferation and migration, 


























Although it is well-established that CRS involves a type 2 immune response and 
respiratory epithelial dysfunction and remodeling, the specific mechanisms and mediators 
that underlie these processes remain unclear. Previous studies have revealed the 
involvement of Wnt signaling in CRS. We hypothesized that Wisp1, a downstream 
mediator of Wnt signaling, may be involved in the inflammation and epithelial barrier 
remodeling characteristic of CRS.  
The objective of this study is to determine the effects of Wisp1 on the human 
nasal epithelium. The following specific aims will be used to test the central hypothesis 
and carry out this objective: 
 
Specific Aim 1: To determine the expression of Wisp1 across the spectrum of CRS using 
bulk RNA sequencing, qPCR and histological analysis of human samples. 
 
Specific Aim 2: To test the effects of Wisp1 on submerged nasal epithelial basal cell 
cultures by measuring proliferation and wound healing.  
 
Specific Aim 3: To test the effects of Wisp1 on nasal epithelial cell differentiation in ALI 








Ethmoid Sinus Tissue Collection 
All samples were collected following approval of the Partners HealthCare 
Institutional Review Board (Boston, Massachusetts) and written consent from all patients. 
Patients with physician-diagnosed CRSwNP, CRSsNP, aspirin-exacerbated respiratory 
disease (AERD), and concha bullosa (CB) were recruited from Brigham and Women’s 
Hospital (Boston, Massachusetts) Allergy and Immunology Clinic and Otolaryngology 
clinics. CB tissue was collected as a control from patients undergoing sinus surgery to 
correct anatomic abnormalities. Tissue from the ethmoid sinus was collected at the time 
of elective endoscopic sinus surgery. The tissue collected was immediately placed in 
RPMI (Corning, 10-040-CV) with 10% FBS (ThermoFisher) and on ice for transport. 




Following tissue collection and processing, human respiratory epithelial cells 
were grown on 1% collagen coated plates (Corning, 3596) in Pneumacult Ex Basal Media 
(StemCell Technologies, 05009) with an added supplement,  hydrocortisone, and 
penicillin/streptomycin according to the manufacturer’s instructions. Cells were grown at 
37C and 5% CO2. At confluency, cells were passaged using Accutase (Sigma Aldrich; 
SCR005).  
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Cell Treatments 
Wisp1: Recombinant human Wisp1 (BioLegend) was resuspended in 10 µL cell 
culture water and 30 µL Pneumacult Ex Basal media. At the time of seeding, cells 
were treated with 1 µg/mL Wisp1. Wisp1 was added to the Pneumacult Ex Basal 
media with subsequent media changes.  
 
Epidermal Growth Factor (EGF): Recombinant human EGF (ThermoFisher) was 
resuspended in PBS to 5 µg/mL. Cells were treated with 2 ng/mL of EGF upon 
seeding and EGF was added to the Pneumacult Ex Basal media with subsequent 
media changes.   
 
Air-Liquid Interface Cell Culture (ALI) 
Human respiratory epithelial cells obtained from CRSwNP and AERD patients 
were expanded in a 1% collagen coated flask and incubated at 37ºC and 5% CO2 in 
Pneumacult Ex Basal Media (StemCell Technologies; 05009). At confluency, the cells 
were lifted using Accutase (Sigma Aldrich; SCR005). 200 µL of cells at 1x105 cells/well 
in Pneumacult Ex Basal Media were transferred to transferred to the apical chamber of 
1% collagen coated transwells (Corning, 3470) in a 24-well plate. Transwells with a pore 
size of 0.4 µm and diameter of 6.5 mm were used. 500 µL of Pneumacult Ex Basal Media 
was also added to the basal chamber. The cells were incubated at 37ºC and 5% CO2 for 
48 hours, at which point the cell culture was converted to an air-liquid interface cell 
culture. The media from the apical chamber was carefully removed using a P200 pipette, 
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and the media from the basal chamber was removed via suction. 500 µL of Pneumacult 
ALI Medium (StemCell Technologies, 05002) was added to the basal chamber. 1 µg/mL 
Wisp1 was also added to the media at this time. The cells were incubated at 37ºC and 5% 
CO2 for 21 days to form well-differentiated, polarized human respiratory epithelium that 
resembles the in vivo pseudostratified epithelium.  
 
Analysis of published RNA-seq data 
Bulk RNA sequencing (RNA-seq) was performed to allow transcriptomic analysis 
of the heterogenous respiratory epithelium from surgical biopsies across the CRS disease 
spectrum. RNA-seq was performed on basal cell cultures derived from surgical samples 
from CRSwNP, AERD, CRSsNP, and CB patient biopsies using data  published by our 
group in 201817.  
 
Histologic Analyses  
The assay was performed as previously reported26. Briefly, tissue samples were 
fixed in 4% paraformaldehyde, embedded in paraffin, and sliced in 5 µm sections. Tissue 
sections were incubated with either an isotype control or a human anti-Wisp1 primary 
antibody (ab178547) and subsequently incubated with a donkey anti-rabbit secondary 
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RT-qPCR 
RT-qPCR was performed to analyze the expression of cell cycle genes and cell markers 
following Wisp1 and EGF treatments. Total RNA was isolated from 24-well and ALI 
basal cell cultures using the TRIzol RNA extraction method. Basal cells were suspended 
in TRIzol (Life Technologies #15596026) and briefly vortexed following the addition of 
chloroform in a 5:1 ratio. RNA was precipitated using isopropanol and washed with 70% 
ethanol. mRNA was purified and reverse transcribed into cDNA using the Qiagen 
QuantiTect Reverse Transcription Kit (Qiagen #205313). mRNA purification and reverse 
transcription were completed according to the manufacturer’s instructions. cDNA purity 
and concentration was evaluated using a Nanodrop spectrophotometer. RT-qPCR was 
performed to detect the mRNA expression levels of FOXM1, CCNA2, CCNB2, 
MUC5AC, FOXJ1, and TP63. 18S mRNA expression was used as a loading control. The 
custom primers used are listed in Table 1 and the commercial primers are listed as 
follows: MUC5AC (PPH60210J), FOXJ1 (PPH02286B), TP63 (PPH0132F), RPL13A 
(PPR53027), and 18S (PPH0566E). RT-qPCR was performed on Agilent AriaMx in 20 
uL reaction volumes using Agilent Technologies Brilliant III Ultra-Fast SYPR Green 
QPCR Master Mix (Agilent Technologies #600882) and a 10x dilution of cDNA for each 
sample. Two biological replicates and two technical replicates were used for each 
condition. The 2−ΔCt equation was used to determine the relative expression of the target 









Non-commercial primers used for RT-qPCR.  
FOXM1 Forward Primer 5’- CAGGGTGGTCCGTGTAAATAG -3’ 
  Reverse Primer 5’- CTTCTGGCAGTCTCTGGATAA -3’ 
CCNA2 Forward Primer 5’- TCCTCCTTGGAAAGCAAACA -3’ 
  Reverse Primer 5’- GGGCATCTTCACGCTCTATT -3’ 
CCNB2 Forward Primer 5’- GGCTTCCAAGTAGGAGATG -3’ 
  Reverse Primer 5’- CTCGGATTTGGGAACTGGTATAA -3’ 
 
Cell Counting  
Respiratory epithelial cells seeded on a 6-well plate at 1x105 cells/well were 
incubated with Accutase (Sigma Aldrich; SCR005) for 10 minutes at room temperature. 
Cells were spun at 800 rpm for 10 minutes and resuspended in single cell suspension in 
250 µL of Pneumacult Ex Basal media. Using 50 µL of the single cell suspension, a 2x 
dilution was prepared using Trypan Blue (Sigma, T8154-20ML). The number of cells 
were counted using a hemocytometer (Hausser Scientific, 3100. The average number of 
cells in each grid was calculated and multiplied by the dilution factor and volume of the 
single cell suspension to yield the total number of cells obtained from each well of the 6-
well plate.  
 
Methylene Blue Assay 
The methylene blue assay is a method used to quantitatively evaluate cell 
proliferation. Cells are stained with methylene blue, and fluorescence is detected using a 
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fluorescence microplate reader.  The assay was performed as previously reported27. 
Briefly, human respiratory basal epithelial cells were plated on 1% collagen coated 24 
well plates at a density of 5x104 cells/well. The cells were incubated at 37ºC and 5% CO2 
for 48 hours with 1 µg/mL Wisp1 and 2 ng/mL EGF. Following the incubation period, 
the cells were washed with 500 µL of PBS then stained with 200 µL of the methylene 
blue solution, which consisted of HBSS + 1.25% glutaraldehyde + 0.6% methylene blue 
(Sigma, 52015). Following a 1 hour incubation at 37ºC and 5% CO2, the plate was rinsed 
6 times in distilled water and briefly left to air dry. 400 µL of the elution solution was 
then added to each well (50% ethanol + 49% PBS + 1% acetic acid) and placed on a plate 
rotator at room temperature for 15 minutes. The contents of each well were transferred to 
microcentrifuge tubes and centrifuged at 12,000 g for 3 minutes. The supernatant was 
transferred to a 96 well plate in duplicate for each sample and read on a microplate reader 
at 570 nm wavelength.  
 
Wound Healing Assay 
Human respiratory epithelial cells were plated on a 24 well plate at a density of 
5x104 cells/well, treated with 1 µg/mL Wisp1 or 2 ng/mL EGF, and incubated at 37ºC 
and 5% CO2 for 48 hours. Using a P1000 pipette tip, a scratch was made down the 
midline of the well. Cells were washed with PBS to removed cell debris and Pneumacult 
Ex Basal Medium (StemCell Technologies; 05009) with the indicated treatments was 
added to each well. Using a digital camera (Nikon, D5100) attached to an inverted 
microscope, images were taken at time 0 and 24 hours. The extent of wound healing and 
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ability of the cells to overcome contact inhibition was determined by the distance 
traversed by the migrating cells into the uncovered area. The uncovered area was 
quantified using Image J software.   
 
Immunofluorescence Analysis 
Human respiratory epithelial cells were grown on 1% collagen coated coverslips 
(Neuvitro, GG-12-Pre) at 5x104 cells/well. The cells were treated with 1 µg/mL Wisp1 
and 2 ng/mL EGF and incubated for 14 days at 37ºC and 5% CO2. At 14 days, the cells 
were fixed with 4% paraformaldehyde for 30 minutes at room temperature, then 
subsequently blocked for 1 hour at room temperature with 3% donkey serum in 
permeabilization buffer: 0.1% saponin, 0.3% BSA, 0.1% TX-100, 1x PBS, 0.05% NaN3, 
and water to the final volume of 5 mL. Primary antibodies were diluted with 
permeabilization buffer, and applied to the cells overnight, at 4 ºC. Rabbit anti-human α-
Cytokeratin 5 (KRT5) (1:1000; ab52635) was used to identify basal cells of the 
respiratory epithelium; rabbit IgG (1:1000; ab37415) was used as an isotype control. 
HRP-conjugated Alexa Fluor 555 donkey anti-rabbit secondary antibodies (1:500; 
ab150062) were diluted in PBS and applied to the sample for 30 minutes. Nuclei were 
counterstained with DAPI and the slides were mounted using fluorescent mounting 
medium (ab104139). All images were acquired at Brigham and Women’s Confocal 
Microscopy Core Facility with a Zeiss LSM 800 with Airyscan confocal system on a 
Zeiss Axio Observer Z1 inverted microscope with 10× Zeiss oil (0.30 numeric aperture) 
and 20× Zeiss (0.8 numeric aperture) objectives, as previously described26. 
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Statistical Analysis 
Normally distributed data was analyzed for statistical significance using an 
unpaired student’s t-test between CRS patient samples. For basal cell and ALI cultures, 
paired student’s t test was used. Statistical significance is represented by *, and is defined 
as P<0.05. All of the results are presented as a mean ± SEM. All data was analyzed using 



































Wisp1 is Aberrantly Expressed in Basal Cells of Nasal Polyp Epithelium 
Wisp1 is a matricellular protein that is most commonly known to be produced and 
secreted by fibroblasts and epithelial cells21. The findings presented by Boscke et al., 
(2017) and Ordovas-Montanes et al., (2018), suggested that the Wnt-pathway genes are 
upregulated in CRSwNP patients, including the upregulation of immediate Wnt pathway 
mediators and downstream effectors.  
To extend these results and investigate the expression of Wisp1 in the respiratory 
epithelium of patients across the CRS disease spectrum, we analyzed published RNA-seq 
data to examine the transcriptomes of human respiratory epithelial cells. RNA-seq 
analysis compared the transcriptomes of AERD, CRSwNP, CRSsNP, and CB derived 
primary respiratory epithelial cell cultures (n=27). WISP1 mRNA expression was found 
to be significantly upregulated in AERD and CRSwNP samples compared to CRSsNP 
and CB samples (P<0.05) (Figure 3).  
 
 











We next performed RT-qPCR to examine the WISP1 mRNA expression in 
CRSwNP, AERD, CRSsNP, and CB tissue directly ex vivo. Using 23 tissue samples 
(n=23), WISP1 expression was found to be significantly increased in CRSwNP and 
AERD basal cells compared to CRSsNP and CB tissue (P >0.05) (Figure 4).  
 
 
Figure 3. WISP1 expression profile determined by bulk RNA sequencing of 
AERD, CRSwNP, CRSsNP, and CB derived respiratory basal epithelial cell 
cultures. Each data point represents an independent basal cell culture derived from 
patient tissue. Results are presented as a mean ±SEM; *P<0.05. 
 









To visualize the localization of Wisp1 expression and secretion, we next performed 
immunohistochemistry on CRSwNP tissue. The architecture of a nasal polyp, includes 
the pseudostratified epithelium, thick basement membrane, and collagen-rich submucosa 
No staining was observed with an isotype control antibody (Figure 5A). Wisp1 staining 
demonstrated that in CRSwNP tissue, Wisp1 is expressed in both the epithelial layer and 
submucosa; however, there is greater expression in the epithelium (Figure 5B). Figure 5C 
shows a magnified image of figure 3B to better visualize the respiratory epithelium. Four 
Figure 4. Expression of WISP1 in human sinonasal tissue obtained from CB, 
CRSsNP, CRSwNP and AERD tissue samples. Total RNA was isolated from 
sinonasal tissue and reverse transcribed into cDNA, which was amplified using WISP1 
and RPL13A primers. Results are presented as a mean ±SEM; *P<0.05.   
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Taken together, our data shows the expression of WISP1 mRNA and protein in 
CRSwNP epithelium. Our results highlight the aberrant expression of Wisp1 localized to 
the respiratory epithelium, particularly the basal cells.  
 
Wisp1 Does Not Increase Cell Proliferation But Enhances Wound Healing in Vitro 
Several studies have reported the proliferative effect of Wisp1, in cancer and fibrotic 
diseases21,28. To investigate whether Wisp1 could induce proliferation in basal cells of the 
respiratory epithelium, we treated primary respiratory epithelial cells obtained from 
Figure 5. Immunohistochemical staining of CRSwNP tissue showing abundant 
Wisp1 protein expression and localization in the respiratory epithelial layer. A) 
CRSwNP tissue stained with an isotype control or B) a human anti-Wisp1 primary 
antibody and subsequent anti-mouse secondary antibody conjugated to HRP. Red 
staining is indicative of Wisp1 protein. C) A magnified image of B) showing the 
respiratory epithelial layer, basement membrane, and immediate submucosa. 
Representative images from 4 biological replicates is shown, and no statistical analyses 
were performed as the results were analyzed qualitatively.  
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CRSwNP and AERD surgical biopsies for 48 hours with 1 µg/mL of Wisp1. Treatment 
with Wisp1 did not significantly increase cell numbers compared to an untreated control 
as determined by cell counting with trypan blue and a hemocytometer. A 2 ng/mL EGF 
treatment was used as a positive control and resulted in increased proliferation compared 











Figure 6. Proliferation of respiratory basal epithelial cells in response to Wisp1. CRSwNP 
and AERD derived basal cells (n=3) were stimulated with 1 µg/mL Wisp1, 2 ng/mL EGF, or left 
untreated for 48 hours in a collagen-coated 6-well plates. Basal cells were seeded at 1x10
5
 
cell/well. Cell number was determined using Trypan blue staining and a hemocytometer. Paired 
t-tests were performed between samples, and the difference between sample means was not 
significant (ns) (P>0.05). 
 













To determine the proliferative effect of Wisp1, the methylene blue assay was 
performed.  The methylene blue assay detected fluorescence emitted from dye retained 
Figure 7. Proliferation in respiratory basal epithelial cells in response to Wisp1 according 
to the methylene blue assay. CRSwNP and AERD derived basal cells (n=4) were stimulated 
with 1 µg/mL Wisp1, 2 ng/mL EGF, or left untreated for 48 hours in a collagen-coated 24 well 
plates. Basal cells were seeded at 5x10
4
 cells/well. Results are presented as mean optical density 
(±SEM) detected at 570 nm. Paired t-tests were performed between samples, and the difference 
between Wisp1 treated and control sample means was not significant (ns). *P<0.05 
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by the cells, which was proportional to the cell number27.  Cells treated with 1 µg/mL 
Wisp1 did not show a significant increase in proliferation compared to an untreated 
control. Again, a 2 ng/mL EGF treatment was used as a positive control, which results in 
significantly increased proliferation compared to the control as determined by a paired t-
test (P<0.05) (Figure 7).  
 
The expression of hallmark cell cycle genes was examined by qPCR following Wisp1 
and EGF treatment. Forkhead box protein M1 (FOXM1), cyclin A2 (CCNA2), and cyclin 
B2 (CCNB2) are cell cycle genes that are upregulated in proliferation of basal cells in the 
respiratory epithelium29. Following a 48 hour treatment of Wisp1, the expression of the 
cell cycle genes relative to 18S mRNA expression and normalized to the untreated control 
were compared. Treatment of basal cells with 1 µg/mL of Wisp1 did not significantly 
upregulate the expression of cell cycle genes (Figure 8). Treatment with 2 ng/mL EGF 

































Wnt pathway mediators are thought to impair contact inhibition, allowing increased 
cell migration and epithelial-mesenchymal transition (EMT)30. We performed a wound 
healing assay to investigate the ability of Wisp1 to impact cell migration. Respiratory 
basal epithelial cells were treated with1 µg/mL Wisp1 and cultured until confluent. At 
confluency, a scratch was made down the midline of the confluent monolayer of basal 
cells. A 2 ng/mL EGF treatment was used as a positive control. Wisp1 and EGF 
significantly increased basal cell migration compared to the untreated control (P<0.05) 




Figure 8. Expression of cell cycle genes FOXM1, CCNA2, and CCNB2 in 
response to Wisp1 in human respiratory basal cells compared to an untreated 
control. Basal cells were cultured on a 1% collagen coated 24 well plate for 48 
hours. Cells were either treated with 1 µg/mL Wisp1, 2 ng/mL EGF, or left 
untreated (n=4). Results are presented as a mean (±SEM). Paired t-tests were 
performed between samples, and the difference between sample means was not 
significant (ns) (P>0.05).    
 



































To further examine the effect of Wisp1 on cell migration, basal cells were grown 
on collagen coated coverslips for 14 days. The density of basal cells was visualized using 
immunofluorescence, in which basal cells were stained for basal cell marker, KRT5. 
Confocal microscopy and Image J analysis revealed that cells treated with Wisp1 and 
EGF grew to a greater density compared to the untreated control (Figure 10).  
Figure 9. Wisp1 increases migration and wound closure in respiratory basal 
epithelial cells. A) Basal cells seeded at 5x104 cells/well were cultured until confluent 
in a collagen-coated 24-well plate (n=2). A scratch was made down the midline of the 
well in the following groups: untreated control; stimulated with 1 µg/mL Wisp1; 
stimulated with 2 ng/mL EGF (positive control). Images of the wound were taken at 
time 0 and 24 hours using a digital camera attached to an inverted microscope. B) The 
percent change in area covered by the basal cells after 24 hours was determined using 
Image J for untreated, and Wisp1 and EGF treated basal cells. Results are presented 
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Figure 10. Wisp1 increased the density of respiratory basal epithelial cells compared 
to an untreated control evidenced by indirect immunofluorescence of KRT5 
expression. Basal cells were grown on collagen coated coverslips for 14 days and A) left 
untreated, B) treated with 1 µg/mL Wisp1, of C) 2 ng/mL EGF. Basal cells were directly 
stained with rabbit anti-human KRT5 primary antibody or D) and isotype control. Then, 
cells were fluorescently labelled using an HRP-conjugated donkey anti-rabbit Alexa Fluor 
555 secondary antibody. Orange fluorescence represents KRT5 expression. Cells were 
counterstained with DAPI, shown by blue fluorescence. E) The average cell count per 
region of interest (ROI) was calculated using Image J. No statistical analysis was 
performed, as only one sample was analyzed (n=1).   
 
 
Wisp1 Decreases Epithelial Differentiation in Air-Liquid Interface Cell Cultures 
Air-liquid interface (ALI) cell cultures are used in respiratory epithelium research 
to model the in vivo upper airway epithelium and enforce strong terminal 
differentiation31. The findings we have presented suggest that Wisp1 is present in the 
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population. ALI cell cultures were used to investigate the impact of Wisp1 on the 
differentiation of the respiratory epithelium.  
To extend the in vitro results presented by Boscke et al., (2017), in which Wnt 
pathway mediators were reported to decrease the heterogeneity of the respiratory 
epithelium, we performed RT-qPCR on ALI cell cultures stimulated with Wisp1. 
MUC5AC, FOXJ1, and TP63 were used to examine the impact of Wisp1 on the 
expression of basal cell, mucus cell, and ciliated cell markers, respectively. We examined 
the expression of MUC5AC, FOXJ1, and TP63 relative to 18S at days 0, 1, 5, 10, 15, and 
21 of the ALI cell culture incubation (n=3). We found significantly increased expression 
of FOXJ1 in Wisp1 treated basal cells compared to the control at day 5 (P<0.05). We also 
found significantly increased expression of TP63 in Wisp1 treated basal cells compared 



















Figure 11. The change in expression of MUC5AC, FOXJ1, and TP63 in response 
to Wisp1 throughout the 21 day ALI basal cell culture period. Basal cells derived 
from CRSwNP and AERD surgical biopsies (n=3) were treated with 1 µg/mL Wisp1 
cultured at ALI for 21 days. RT-qPCR was performed at day 0, 1, 5, 10, 15, and 21. 
The results are presented as the fold change of expression relative to 18S and 
normalized to the control (±SEM). Paired t-tests were performed between sample. 
*P<0.05.    
 




Wisp1, a secreted matricellular protein, is a downstream mediator of the Wnt 
signaling pathway, which has gained attention recently due to its increased expression in 
cancer and fibrotic disease32. Wisp1 has been noted to play a role in cancer, in which its 
expression increases proliferation of the epithelium and promotes tumorigenesis21,33. 
Wisp1 has also be implicated to wound healing and repair, where it promotes epithelial 
mesenchymal transition (EMT), cell migration, and invasion34. Finally, Wisp1 may lead 
to expansion of the extracellular matrix (ECM) with concomitant fibroblast proliferation 
and migration35. Taken together, previous reports provide evidence for the role of Wisp1 
in proliferation, migration, cell survival, and metastasis. The role of Wisp1 in chronic 
rhinosinusitis (CRS), specifically chronic rhinosinusitis with nasal polyps (CRSwNP) and 
aspirin-exacerbated respiratory disease (AERD) is complex and multifactorial. 
Upregulation of Wnt pathway signaling in CRSwNP and AERD respiratory basal 
epithelial cells has been supported by previous studies17,18. The expression of Wisp1 in 
CRS and its effect on basal cell proliferation, cell migration, and differentiation has not 
been tested. Using submerged and air-liquid interface (ALI) cell cultures, the current 
study aimed to elucidate the role of Wisp1 on basal cell proliferation, migration and 
differentiation.  
Our results demonstrate that Wisp1 is significantly upregulated in polyp disease 
compared to non-polyp disease. Our data indicates that Wisp1 did not significantly 
increase the proliferation of basal cells following a short-term treatment of Wisp1, but the 
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number of replicates performed so far is low, limiting our confidence in this result. Cell 
migration and wound healing, however, was significantly increased in response to Wisp1. 
Finally, Wisp1 decreased the expression of genes associated with basal cell 
differentiation.  
It is well established that Wnt pathway activation can increase proliferation of 
respiratory epithelial cells18. Although, there is little evidence to date regarding the 
proliferative effect of Wisp1 on the respiratory epithelium, previous studies suggest that 
Wisp1 can induce proliferation of the lower airway alveolar epithelial cells21.Treatment 
of mouse primary alveolar type II (ATII) cells with recombinant Wisp1 led to ATII cell 
hyperplasia and lung fibrosis. Likewise, treatment with Wisp1 neutralizing antibodies 
attenuated the proliferative effect of Wisp1 and offset the lung fibrosis21.  In the setting of 
idiopathic pulmonary fibrosis, primary human lung fibroblasts were either transfected 
with siRNA against Wisp1 or treated with Wisp1 neutralizing antibodies. 
Downregulation or inhibition of Wisp1 significantly decreased fibroblast proliferation 
compared to an untreated control36. The proliferative effect of Wisp1 has also been 
reported in other tissues with significant Wisp1 expression, such as the stomach. In a 
study in which Wisp1 expression was down-regulated using siWisp1 transfection, 
decreased expression of Wisp1 resulted in decreased proliferation and colony formation 
of gastric carcinoma cells. Furthermore, cell cycle arrest and apoptosis were favored. 
From these results, it was inferred that Wisp1 enhances proliferation and survival of 
gastric epithelial cells37. Despite evidence for the proliferative effect of Wisp1, our study 
was unable to replicate this result. Under the conditions tested, our in vitro proliferation 
 
    
34 
studies suggested that Wisp1 cannot significantly increase proliferation in respiratory 
basal cells. We treated basal cells for 48 hours and did not see a significant increase in 
proliferation. Interesting, Boscke et al., (2017) reportedly treated basal cells with 
recombinant human WNT3A for a duration ranging from 6-96 hours depending on the 
individual sample. It seems possible that the short-term treatment of Wisp1 done in our 
study was not a long enough treatment period to produce significant increases in 
proliferation. This points to the vast diversity that exists between human samples. 
Different conditions and inclusion of a greater sample size should be considered to 
further examine the proliferative effect of Wisp1 on the upper respiratory basal epithelial 
cells.   
Wnt signaling has been implicated with epithelial to mesenchymal transition 
(EMT) in addition to proliferation. EMT represents a disturbed state of epithelial 
homeostasis, in which epithelial cells dedifferentiate and favor a mesenchymal cell 
phenotype rather than undergo terminal differentiation38. In EMT, epithelial cells lose 
cellular polarity, become migratory, and down regulate the expression of adhesive, 
junctional proteins, such as E-cadherin, which ultimately favors the mesenchymal cell 
phenotype39. EMT is  central process involved in wound healing and repair in response to 
injury, but there is increasing evidence that dysregulation of EMT can precipitate cancer 
and fibrotic disease. The chronic inflammatory environment seen in CRSwNP and AERD 
may be the trigger for EMT and accelerate polyp formation30. Wnt pathway dysregulation 
has been indicated as causative of EMT30. Recently, Bae et al., (2020) suggested that 
Wnt-mediated EMT is related to the pathogenesis of nasal polypogenesis. Using a murine 
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model, nasal polyps were induced by ovalbumin sensitization and subsequently 
challenged with staphylococcal enterotoxin B (Apc)Min/+. ApcMin/+-induced mice had 
significantly upregulated expression of Wnt pathway mediators, and overexpression of 
EMT markers compared to a control. Indocyanine green-001 (ICG-001), a Wnt pathway 
inhibitor, was also used to study the impact of Wnt expression on EMT. Administration 
of ICG-001 significantly decreased the nasal polypoid lesions and EMT markers 
compared to a control30. Loss of contact inhibition is another hallmark of EMT and cell 
density is inversely correlated to contact inhibition, as demonstrated by Pavel et al., 
(2018). Contact inhibition is a fundamental property of cells, in which confluency 
induces cell cycle arrest through transcriptional regulators. In physiological and 
pathological states, such as embryogenesis, wound healing, and cancer, contact inhibition 
is reversed leading to uncontrolled proliferation40. There is evidence to suggest that loss 
of contact inhibition precipitates EMT in epithelial cells41. The results of our wound 
healing assay suggest that Wisp1 is capable of increasing migration of respiratory basal 
cells. Furthermore, our immunofluorescence staining of KRT5 in basal cells demonstrates 
that Wisp1 can increase the density of basal cells grown on collagen-coated coverslips. 
The short-term proliferation assays, in which basal cells were treated with Wisp1 for 48 
hours did not produce significant results. Our wound healing and immunofluorescence 
assays illustrate the result of a longer duration of Wisp1 treatment. Basal cells in the 
wound healing and immunofluorescence assays were treated with Wisp1 for 72 hours and 
14 days, respectively. Long-term exposure of respiratory basal cells to Wisp1 may 
facilitate its effect on proliferation and EMT. In nasal polyp pathogenesis, the chronic 
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inflammatory environment reinforced by continued epithelial injury and impaired wound 
healing may sustain long term increased in Wisp1 expression and thus, increased basal 
cell proliferation and migration.  
 ALI cell culture systems have emerged as a powerful tool in epithelia biology 
research because they mimic many of the in vivo characteristics of the epithelium. ALI 
cell cultures of the respiratory epithelium produce mucus with a similar composition of in 
vivo airway secretions42, and can differentiate to produce transcriptional profiles that 
recapitulate the in vivo airway epithelia31. In our study, we used ALI cell cultures to 
examine the effect of Wisp1 on basal cell differentiation. We found that the effect of 
Wisp1 on basal cell differentiation varies along the time course of the ALI culture period. 
Wisp1 decreased the expression goblet and ciliated cell markers and increased the 
expression of basal cell makers. It can thus be said that Wisp1 decreased the ability of 
basal cells to differentiation at ALI. Interestingly, the ability of Wisp1 to decrease basal 
cell differentiation was dampened at 21 days, where no difference in the expression of 
goblet, ciliated, or basal cell markers was observed. The greatest difference in expression 
of MUC5AC, FOXJ1, and TP63 between Wisp1 stimulated basal cells and the control 
was seen prior to 10 days. Our results point to the possibility that in a 21 day ALI cell 
culture, basal cell fate is determined in the first 10 days of the cell culture period. 
Previous studies have suggested that the CRSwNP and AERD polyp epithelium has a 
global decrease in epithelial cell diversity. Specifically, there is an increase in basal cells 
and decrease in goblet and ciliated cells17. Despite the chronic exposure of the polyp 
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epithelium to increased expression of Wisp1, decreased basal cell differentiation and lack 
of heterozygosity may be established in the initial stages of basal cell differentiation.   
The demand for further investigation into the impact of Wisp1 on the respiratory 
epithelium is reinforced by our findings that Wisp1 is found in tissue derived from 
patients across the CRS disease spectrum. We detected Wisp1 in the tissue of CRSsNP, 
CRSwNP, and AERD biopsies. Although Wisp1 is expressed across the CRS disease 
spectrum, WISP1 expression is significantly greater in basal cells of polyp disease 
compared to non-polyp disease. Bulk RNA sequencing of basal cell cultures derived from 
patients across the CRS disease spectrum indicated that WISP1 is significantly 
upregulated in CRSwNP and AERD epithelium compared to CRSsNP and CB 
epithelium. Thus, we can infer that greater expression of WISP1 detected by RT-qPCR in 
CRSwNP and AERD tissue, is due to increased expression by the respiratory basal 
epithelial cells. Furthermore, our histologic analyses highlight the localization of Wisp1 
to the polyp epithelium, which supports further this conclusion.  
The results of this study and those reported by others suggest that Wisp1 may 
contribute to the pathogenesis of CRS by increasing basal cell migration and decreasing 
basal cell differentiation. Enhanced cell migration is a hallmark feature of EMT and thus, 
our results may suggest that Wisp1 is involved in EMT. EMT and decreased epithelial 
heterozygosity are characteristics of the nasal polyp epithelium, which emphasizes the 
clinical relevance of our findings. Wnt signaling, and specifically, upregulation of the 
downstream mediator, Wisp1, may contribute to the initiation and maintenance of 
epithelial dysfunction and remodeling in polyp disease.   
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Several limitations of our study must be addressed. Our submerged and ALI cell 
cultures were limited to a low sample size due to the limited availability of human tissue. 
Because of the current COVID-19 pandemic, a limited number of polyp resection 
surgeries were conducted and consequently, the quantity and diversity of tissue samples 
were decreased. Therefore, under the conditions tested our results were often not 
significant or generalizable. Additionally, the current study did not examine the effect of 
Wisp1 on non-polyp epithelium. Although we acknowledged the expression of WISP1 
across the CRS disease spectrum, we did not investigate the effect of Wisp1 on basal cell 
proliferation, cell migration, and differentiation in non-polyp disease. To address these 
limitations, the study should be extended with a larger sample size and greater patient 
diversity to ensure replicable and generalizable results. Tissue derived from CRSsNP and 
CB disease states should also be included to investigate the impact of Wisp1 across the 














Wisp1, also known as CCN4, is a member of the CCN protein family. The CCN 
protein family consists of 6 secreted, ECM-associated proteins—CCN1 to CCN6—
involved in a wide range of functions including cell adhesion, migration, cell survival, 
differentiation, and wound healing43. The unifying feature of CCN proteins is their 
structure, which consists of four conserved domains: insulin-like growth factor binding 
protein-like domain (IGFBP);  von Willebrand factor type C repeat domain (VWC); 
thrombospondin type-1 repeat domain (TSP1); and domain (CT)44.  
The multimodular structure of CCN proteins enables interaction with several 
other proteins, including integrins, growth factors, cytokines, and other ECM proteins. 
The biological function conferred by each CCN protein is a function of the domain-
ligand interaction. For example, insulin-like growth factors (IGF) were once considered 
the primary ligand for the IGFBP domain; however, affinity-labelling and ligand blotting 
studies have revealed that the IGFBP domain of CCN proteins binds IGFs with low 
binding affinity. Despite near sequence homology to classical IGFBPs, it seems unlikely 
that the IGFBP domain of CCN proteins directly interacts with IGFs. The IGFBP domain 
has been associated with cell proliferation and differentiation; therefore, it is plausible 
that the domain is involved at another level of IGF signaling45. The VWC domain 
contains a cysteine-rich repeat that is a motif commonly seen in procollagen, 
thrombospondin, and glycosylated mucins, and is suggested to regulate bone 
morphogenic proteins (BMP) and transforming growth factor-β (TGF-β) signaling46. 
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Immunoprecipitation and western blot analysis revealed that CCN3 interacts with BMP-
2, and was found to downregulate its expression and inhibit BMP-2-induced 
differentiation of osteoblasts47.  The TSP-1 domain consists of a collection of motifs, 
similar to those found in thrombospondins and spondins, and components of the 
complement pathway. Via interactions with collagen V, fibronectin, TGF-β, and heparin, 
four main functions of the TSP-1 domain have been described: cell adhesion, inhibition 
of angiogenesis, recognition of growth factors, glycosaminoglycan-binding sites. The 
proposed role of the TSP-1 domain in CCN proteins is adhesion through interactions with 
integrins48. Finally, the CT domain is similar to those found in VEGF, TGF-β, and BMPs, 
among other growth factors. The CT domain is thought to bind heparin following 
dimerization. In concert with the TSP-1 domain, the CT domain may be involved in cell 
adhesion and integrin binding49. Immunoprecipitation and western blot analysis revealed 
that the CT domain of CCN3 associates with the epidermal growth factor motifs of Notch 
signaling mediators, and consequently inhibits the differentiation of cardiac myoblasts49.  
The biological function of several CCN proteins has been considered; however, 
the function conferred by the individual domains is still largely unknown. To further 
investigate the role of Wisp1/CCN4 in the pathogenesis of CRS, protein recombination 
studies will be performed to decipher the role of the CCN protein domains. To examine 
the role of each domain, a plasmid expressing human Wisp1 will be edited to remove 
each domain. Primers specific for each domain will enable cloning of the deletion 
mutants (Figure 12). Gibson Assembly can then be performed to generate recombination 
constructs. Gibson Assembly is a one-step reaction involving a 5’ exonuclease, DNA 
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polymerase, and DNA ligase used to seamlessly assemble gene recombination 
constructs50. The basic approach utilizes an exonuclease to remove nucleotides from 
double stranded DNA and create single stranded overhangs. DNA polymerase will 
specifically reanneal the complementary single strands and finally, DNA ligase will seal 
the nicks51. The deletion mutants will be transfected into HEK293 and A549 cells 
(transformed lung epithelial cells), and primary basal cell cultures to investigate the 



























In addition to Wisp1 structure-function relationship studies, the current study 
must be repeated with a greater sample size to obtain significant findings. We will 
A B C 
D E 
Figure 12. Wisp1 deletion mutants created by Gibson Assembly. A) The complete 
Wisp1 protein with the IGFBP, VWC, TSP-1, and CT domains specifically labelled. 
Additional common vector motifs have been included. A C-terminal Myc tag was added 
for protein detection. B) Forward and reverse primers were created surrounding the IGFBP 
domain. PCR generated IGFBP deletion mutants, which will be subject to Gibson 
Assembly to create mutant Wisp1 protein. PCR and Gibson Assembly will also be done 
with C) VWC, D) TSP-1, and E) CT domain deletion constructs.  
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continue to collect tissue samples from patients with AERD, CRSwNP, CRSsNP, and CB 
following sinus surgery performed at Mass General Brigham associated hospitals. We 
will repeat the proliferation studies, wound healing assay, and ALI cell cultures to 
determine the effect of Wisp1 on basal cell proliferation, EMT, and differentiation. 
Furthermore, we will perform immunofluorescence on the ALI membranes to visualize 
the state of epithelial differentiation. By staining for KRT5, MUC5AC, and FOXJ1, we 
can investigate the effect of Wisp1 on basal cell differentiation in cultures stimulated 
with Wisp1 compared to an unstimulated control. We will also perform histological 
sectioning of the ALI membranes to examine the cellular composition of the epithelium. 
Hematoxylin and eosin staining and immunohistochemistry will be performed to examine 
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